PPT-Are ACE Inhibitors and Angiotensin Receptor Blockers associated with all-cause mortality

W Hinton 12 H DambhaMiller 3 MFeher 1 J Sheppard 1 MJoy 1 N Munro 24 S de Lusignan 15 1 Nuffield Department of Primary Care Health Sciences University of Oxford Oxford UK. for Hypertension. presented by Jerad Bailey, Pharm D. Click image to download. Clinician Resource. Today’s Guest Speaker. Jerad Bailey, Pharm . D. Lead Pharmacist, . Cabin . Creek Health Systems. BA, . Drugs Acting on the Renin-Angiotensin-Aldosterone System. Physiology of the renin-angiotensin-aldosterone system. Angiotensin-converting enzyme inhibitors. Angiotensin II receptor blockers. Aldosterone antagonists. Dr. . Naser. Ashraf . Department of Basic Medical Sciences . College of Medicine . Majmaah University . Objectives . List major drug groups used in treatment of heart failure . Explain mechanism of action of digitalis and its major effects . MARLON T. CO,MD. DISCLOSURE. Advisory board of Merck Philippines. Ps-DZ, 2009. Global Leading Risks for Death, 2010. Systolic blood pressure > 115 mmHg. Global Burden of Disease Study 2010 , . Lancet . Blockers. :. Impact on Adverse Outcomes in Hospitalized Patients . with Severe Acute Respiratory Distress Syndrome Coronavirus 2 (SARS-CoV-2). THE BRACE CORONA TRIAL. Renato D. Lopes, MD, PhD. on behalf of the BRACE CORONA Investigators. IN. TYPE I DIABETIC NEPHROPATHY. DR.NASIM MUSA. Type I –IDDM is characterized by. The abrupt onset of symptoms. Insulinopenia. Dependence on injected insulin for life. Proneness to . ketoacidosis. .. Dr.AZDAKI. . (cardiologist).  Initial . monotherapy. is successful in many patients with mild primary hypertension (formerly called "essential" hypertension). . However, single-drug therapy is unlikely to attain goal blood pressure in patients whose blood pressures are more than 20/10 mmHg above goal. . Assistant lecturer Ola . N. assr. 12 Nov 2015 MSc Clinical Pharmacy . Aim and objectives. By the end of the session, the students will be able to:. Know indications, side effects, contraindications, doses and drug interactions of all drugs mentioned in the list.. System. The Cardiovascular Continuum . Myocardial Infarction. Heart Failure. End-Stage Heart Disease. Plaque Rupture. Risk Factors. Hypertension. Hyperlipidemia. Diabetes. Atherosclerosis. Endothelial Dysfunction. enzyme inhibitors (ACE inhibitors). inhibit the conversion of angiotensin I to angiotensin II.. The. . main . indications of ACE inhibitors are shown below.. Heart Failure. ACE inhibitors are used in all grades of heart failure, . %). Clinicians should aim to screen for and . treat comorbidities . such as hypertension, CAD, diabetes mellitus, anemia, and sleep-disordered breathing, as these conditions tend to exacerbate HF. . HF . BP. Congest-ion*. Haemo. -globin. K. +. GFR. BNP#. Echo. Diuretics. . . . . . . . ACEi/ARB. . . . I. ARNI. . . . I. I. β. -Blocker. R?. . R?. . I. MRA. . when resting systolic blood pressure exceeds . 130 or diastolic . blood pressure exceeds 80 mm . Hg.. Even stage 1 hypertension (<140/90. ) has been reported to increase the risk of end-organ damage. Converting. . Enzyme. . Inhibitors. . or . Angiotensin. . Receptor. . Blockers. . Use and. . Covid-. 19. . Infection . Among. . Patients with. . Hypertension. Jaejin. . An. ,. . Rong. . Wei,.